Skip to main content
ADGI logo

Adagio Therapeutics, Inc. (ADGI) Stock Analysis

DELISTED

What happened to Adagio Therapeutics, Inc. (ADGI) stock?

Adagio Therapeutics, Inc. (ADGI) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $506M| Vol: 535.0K|

Market cap $506M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Adagio Therapeutics, Inc. (ADGI).

Last analyzed: Jun 13, 2026
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing antibody-based solutions for infectious diseases in the U.S. Its primary focus is on ADG20 (adintrevimab), a neutralizing antibody currently in Phase 3 clinical trials for coronavirus disease treatment and prevention.

Adagio Therapeutics, Inc. (ADGI) Healthcare & Pipeline Overview

Employees101
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Jun 13, 2026

More about this archive record

Can I still buy ADGI shares?

No. ADGI stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ADGI elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before ADGI stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Adagio Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.